000 01254 a2200313 4500
005 20250517170648.0
264 0 _c20190627
008 201906s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/j.ajkd.2017.06.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRein, Joshua L
245 0 0 _aMarijuana and Cannabinoids in ESRD and Earlier StagesĀ of CKD.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_c02 2018
300 _a267-274 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnalgesics
_xpharmacology
650 0 4 _aCannabinoids
_xpharmacology
650 0 4 _aChronic Pain
_xetiology
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aMedical Marijuana
_xpharmacology
650 0 4 _aPatient Acuity
650 0 4 _aRenal Insufficiency, Chronic
_xdiagnosis
650 0 4 _aTreatment Outcome
700 1 _aWyatt, Christina M
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 71
_gno. 2
_gp. 267-274
856 4 0 _uhttps://doi.org/10.1053/j.ajkd.2017.06.020
_zAvailable from publisher's website
999 _c27468440
_d27468440